Tech Company Financing Transactions
Talima Therapeutics Funding Round
Talima Therapeutics, based in San Carlos, scored $2.8 million from De Novo Ventures and U.S. Venture Partners.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$2,818,000
Round
Undisclosed
Investors
De Novo Ventures (Fred Dotzler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
75 Shoreway Rd C
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy we seek to present innovative solutions that overcome drug delivery barriers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Babler
Chief Financial Officer
Paul Denton
VP - R & D
Corinne Bright
Browse more venture capital transactions:
Prev: 3/31/2009: Franklin & Seidelmann Subspecialty Radiology venture capital transaction
Next: 3/31/2009: Xignite venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs